Concepedia

Horst Irlbacher

HI

Statistics

Publications

11

Citations

440

H-Index

11

Active since

2001

Affiliations

Bayer (Germany)(Current)

Heidelberg University

Humboldt-Universität zu Berlin

German Cancer Research Center

Sorbonne Université

Horst Irlbacher is an author at Bayer (Germany) specializing in medicine, pharmacology, and cancer pharmacology.

ORCID

Publications per year

2001–2023

11

Publications

11

Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy

Christina Kober, Julian Roewe, Norbert Schmees et al. · Journal for ImmunoTherapy of Cancer · 2023 · 82 citations · Full text

, , +17

Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel

Tim Ziera, Horst Irlbacher, Anja Fromm et al. · The FASEB Journal · 2009 · 66 citations

, , +17

Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target

Manuel Ellermann, Ashley Eheim, Fredrik Rahm et al. · ACS Chemical Biology · 2017 · 57 citations · Full text

, , +10

Control of replication initiation and heterochromatin formation in <i>Saccharomyces cerevisiae</i> by a regulator of meiotic gene expression

Horst Irlbacher, Jacqueline Franke, Thomas Manke et al. · Genes & Development · 2005 · 55 citations · Full text

, , +17

Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor

Julien Lefranc, Volker Schulze, R.C. Hillig et al. · Journal of Medicinal Chemistry · 2019 · 47 citations · Full text

, , +11

1–5 of 11